This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
P

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Patrick Johnson
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Patrick Johnson
0 views
June 7, 2024

Chapters

Overview of Relapsed Hodgkin Lymphoma Treatment

00:00

Evolving Role of Brentuximab Vedotin

01:18

Salvage Regimens & PD-1 Therapy Efficacy

03:11

Comparing Salvage Regimens & Outcomes

08:28

Key Takeaways & Treatment Strategies

09:50

Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

2024 ASCO® Annual Meeting Insights Hub: Hematologic Oncology Videos

06:26
ecancer

Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients …

Feat. M. Al Malki, S. Devine
09:04
ecancer

ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Mult…

Feat. X. Leleu
27:49
Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Feat. T. Badar
View All

Recommended

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
21:56
Indy Hematology Review

Emerging and Current Treatment for Hodgkin Lymphoma in 2024

Feat. S. Ansell
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
15:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…

Feat. A. Evens
29:26
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in DLBCL and HL

Feat. J. Erika Haydu
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
10:04
Stephen M. Ansell

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

28:11
Total Health

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Feat. M. Rotta
20:49
SOHO Brazil 2024

Summary of Recent Updates in Advanced Hodgkin Lymphoma

Feat. C. Moskowitz
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
14:47
Insights from 2024 EHA Annual Meeting

EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin&#x…

Feat. M. Salamoon
08:59
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in O…

Feat. S. Rutherford
41:20
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lym…

Feat. N. Bartlett
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
30:24
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment of Older Patients With HL in the …

Feat. A. Evens
15:18
UNC Lineberger Comprehensive Cancer Center

Hodgkin Lymphoma Management: Updates for 2023

Feat. N. Grover
12:09
Pooja Khandelwal

Treating Fibrosis and Inflammation in GvHD